GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $33.24 $45.00 Friday, 19th Apr 2024 CRBP stock ended at $39.24. This is 7.42% more than the trading day before Thursday, 18th Apr 2024. During the day the stock fluctuated 11.37% from a day low at $35.79 to a day high of $39.86.
90 days $6.63 $49.87
52 weeks $3.03 $49.87

Historical Corbus Pharmaceuticals Holdings prices

Date Open High Low Close Volume
2021-06-01 $2.25 $2.29 $1.98 $2.05 5 903 519
2021-05-28 $2.01 $2.18 $1.86 $2.17 13 816 427
2021-05-27 $1.85 $2.06 $1.81 $2.04 4 865 828
2021-05-26 $1.76 $1.87 $1.75 $1.86 2 146 539
2021-05-25 $1.69 $1.80 $1.66 $1.78 2 299 302
2021-05-24 $1.77 $1.78 $1.69 $1.69 1 537 654
2021-05-21 $1.71 $1.78 $1.67 $1.77 2 054 654
2021-05-20 $1.60 $1.71 $1.57 $1.70 2 162 327
2021-05-19 $1.56 $1.63 $1.52 $1.62 2 521 710
2021-05-18 $1.59 $1.71 $1.54 $1.63 1 988 726
2021-05-17 $1.64 $1.67 $1.58 $1.59 2 010 579
2021-05-14 $1.36 $1.75 $1.36 $1.67 6 465 567
2021-05-13 $1.48 $1.50 $1.37 $1.39 2 865 985
2021-05-12 $1.47 $1.60 $1.45 $1.49 1 677 078
2021-05-11 $1.42 $1.56 $1.38 $1.52 2 104 274
2021-05-10 $1.62 $1.62 $1.55 $1.57 2 527 889
2021-05-07 $1.54 $1.68 $1.54 $1.65 2 403 228
2021-05-06 $1.64 $1.67 $1.51 $1.54 2 724 069
2021-05-05 $1.66 $1.69 $1.60 $1.69 4 093 161
2021-05-04 $1.71 $1.71 $1.63 $1.67 2 572 911
2021-05-03 $1.79 $1.80 $1.72 $1.72 1 621 813
2021-04-30 $1.83 $1.88 $1.77 $1.80 1 792 250
2021-04-29 $1.91 $1.91 $1.80 $1.89 1 633 839
2021-04-28 $1.80 $1.92 $1.76 $1.88 2 233 985
2021-04-27 $1.85 $1.89 $1.80 $1.82 1 351 006
Click to get the best stock tips daily for free!

About Corbus Pharmaceuticals Holdings

Corbus Pharmaceuticals Holdings Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an anti-integrin monoclonal antibody (mAb) for the treatment of cancer and fibrosis that inhibits the act... CRBP Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT